Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
1.680
-0.060 (-3.45%)
Nov 10, 2026, 2:54 PM EST - Market open
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $596.69 million as of November 10, 2026. Its market cap has decreased by 44.59% in one year.
Market Cap
596.69M
Enterprise Value
686.87M
1-Year Change
-44.59%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since the IPO on November 4, 2021, Evotec SE's market cap has decreased from $9.19B to $596.69M, a decrease of -93.51%. That is a compound annual growth rate of -42.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 596.69M | -47.51% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | -8.26% |
| Nov 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amphastar Pharmaceuticals | 1.22B |
| Harrow | 1.01B |
| Collegium Pharmaceutical | 752.34M |
| Ironwood Pharmaceuticals | 726.77M |
| Alpha Teknova | 481.90M |
| Aquestive Therapeutics | 453.73M |
| Evolus | 450.41M |
| Tilray Brands | 428.25M |